HP, A., MC, H., K, H., F, F., M, T., J, O., . . . T, W. (2024). Comparison of Results from Two Commercially Available In-House Tissue-Based Comprehensive Genomic Profiling Solutions: Research Use Only AVENIO Tumor Tissue Comprehensive Genomic Profiling Kit and TruSight Oncology 500 Assay. The Journal of molecular diagnostics : JMD, 26(11), 1018. https://doi.org/10.1016/j.jmoldx.2024.08.001
Chicago Style (17th ed.) CitationHP, Adams, et al. "Comparison of Results from Two Commercially Available In-House Tissue-Based Comprehensive Genomic Profiling Solutions: Research Use Only AVENIO Tumor Tissue Comprehensive Genomic Profiling Kit and TruSight Oncology 500 Assay." The Journal of Molecular Diagnostics : JMD 26, no. 11 (2024): 1018. https://doi.org/10.1016/j.jmoldx.2024.08.001.
MLA (9th ed.) CitationHP, Adams, et al. "Comparison of Results from Two Commercially Available In-House Tissue-Based Comprehensive Genomic Profiling Solutions: Research Use Only AVENIO Tumor Tissue Comprehensive Genomic Profiling Kit and TruSight Oncology 500 Assay." The Journal of Molecular Diagnostics : JMD, vol. 26, no. 11, 2024, p. 1018, https://doi.org/10.1016/j.jmoldx.2024.08.001.